Search research articles
Contact Us
Filters
Showing results (31-40 of 178) with videos related to
Page
of 18
Sort By:
Expert Opinion on Drug Discovery
|
June 15, 2019
Repositioning rifamycins for Mycobacterium abscessus lung disease
Uday S Ganapathy, Véronique Dartois, Thomas Dick
Frontiers in Microbiology
|
September 16, 2016
Rel Is Required for Morphogenesis of Resting Cells in Mycobacterium smegmatis
Mu-Lu Wu, Chuu Ling Chan, Thomas Dick
Antibiotics (Basel, Switzerland)
|
February 14, 2020
Rifabutin Suppresses Inducible Clarithromycin Resistance in <i>Mycobacterium abscessus</i> by Blocking Induction of <i>whiB7</i> and <i>erm41</i>
Dinah Binte Aziz, Mei Lin Go, Thomas Dick
Antimicrobial Agents and Chemotherapy
|
September 14, 2016
Bedaquiline Targets the ε Subunit of Mycobacterial F-ATP Synthase
Subhashri Kundu, Goran Biukovic, Gerhard Grüber, et al.
Trends in Pharmacological Sciences
|
November 10, 2019
Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide
Pooja Gopal, Gerhard Grüber, Véronique Dartois, et al.
Antimicrobial Agents and Chemotherapy
|
January 22, 2013
Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis
Jansy Sarathy, Véronique Dartois, Thomas Dick, et al.
Molecular Microbiology
|
September 7, 2010
Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis
Thomas Dick, Ujjini Manjunatha, Barbara Kappes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 21, 2020
Reply to Vargas and Farhat: <i>Mycobacterium tuberculosis glpK</i> mutants in human tuberculosis
Hassan Safi, David R Sherman, Thomas Dick, et al.
The Journal of Antimicrobial Chemotherapy
|
July 11, 2013
In silico analyses for the discovery of tuberculosis drug targets
Bevan Kai-Sheng Chung, Thomas Dick, Dong-Yup Lee
Frontiers in Microbiology
|
May 13, 2017
Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome
Wilfried Moreira, Sridhar Santhanakrishnan, Brian W Dymock, et al.
Page
of 18
Search research articles
Search
Showing results (31-40 of 178) with videos related to
Sort By:
Page
of 18
Expert Opinion on Drug Discovery
|
June 15, 2019
Repositioning rifamycins for Mycobacterium abscessus lung disease
Uday S Ganapathy, Véronique Dartois, Thomas Dick
Frontiers in Microbiology
|
September 16, 2016
Rel Is Required for Morphogenesis of Resting Cells in Mycobacterium smegmatis
Mu-Lu Wu, Chuu Ling Chan, Thomas Dick
Antibiotics (Basel, Switzerland)
|
February 14, 2020
Rifabutin Suppresses Inducible Clarithromycin Resistance in <i>Mycobacterium abscessus</i> by Blocking Induction of <i>whiB7</i> and <i>erm41</i>
Dinah Binte Aziz, Mei Lin Go, Thomas Dick
Antimicrobial Agents and Chemotherapy
|
September 14, 2016
Bedaquiline Targets the ε Subunit of Mycobacterial F-ATP Synthase
Subhashri Kundu, Goran Biukovic, Gerhard Grüber, et al.
Trends in Pharmacological Sciences
|
November 10, 2019
Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide
Pooja Gopal, Gerhard Grüber, Véronique Dartois, et al.
Antimicrobial Agents and Chemotherapy
|
January 22, 2013
Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis
Jansy Sarathy, Véronique Dartois, Thomas Dick, et al.
Molecular Microbiology
|
September 7, 2010
Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis
Thomas Dick, Ujjini Manjunatha, Barbara Kappes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 21, 2020
Reply to Vargas and Farhat: <i>Mycobacterium tuberculosis glpK</i> mutants in human tuberculosis
Hassan Safi, David R Sherman, Thomas Dick, et al.
The Journal of Antimicrobial Chemotherapy
|
July 11, 2013
In silico analyses for the discovery of tuberculosis drug targets
Bevan Kai-Sheng Chung, Thomas Dick, Dong-Yup Lee
Frontiers in Microbiology
|
May 13, 2017
Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome
Wilfried Moreira, Sridhar Santhanakrishnan, Brian W Dymock, et al.
Page
of 18